ARCHIVES

FDA Hears More Criticism On Cancer Drug Endpoints; Joint Conferences On Criteria Recommended

This article is from The Cancer Letter archive.

Vol. 15 No. 30 | July 28, 1989

Download PDF Visit The Full Archive

Related Articles

NCI Health Disparities Center Will Attempt To Influence Policy, Harold Freeman Says.

November 3, 2000

Referral Pattern Change Needed For Quality Care, AACR/ASCO Told

May 16, 1975

NCI’s Professional Judgment Budget Outlines Spending of $7.2 Billion

February 13, 2009

Low Prevalence Of Tamoxifen Use For Cancer Prevention

February 26, 2010

DCE Board Sets Aside $2 Million For Radiation Grants Program; Okays Concept For Add-On To ASCUS Trial

October 13, 1995

Voluntary Organizations: Myles Cunningham elected ACS President

November 8, 1996